CTNM

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Contineum Therapeutics, Inc. Class A Common Stock

NASDAQ | CTNM

10.39

USD

$0.00

(

0.00%

)

At Close (As of Nov 4, 2025)

$310.79M

Market Cap

-

P/E Ratio

-2.25

EPS

$20.23

52 Week High

$3.35

52 Week Low

HEALTHCARE

Sector

CTNM Chart

Recent Chart
Price Action

CTNM Technicals

Tags:

CTNM Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$258K
Total Revenue $0
Cost Of Revenue $258K
Costof Goods And Services Sold $258K
Operating Income -$51M
Selling General And Administrative $12M
Research And Development $38M
Operating Expenses $51M
Investment Income Net -
Net Interest Income $8.9M
Interest Income $8.9M
Interest Expense $0
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $258K
Income Before Tax -$42M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$42M
Comprehensive Income Net Of Tax -
Ebit -$42M
Ebitda -$42M
Net Income -$42M

Revenue & Profitability

Earnings Performance

CTNM Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $213M
Total Current Assets $206M
Cash And Cash Equivalents At Carrying Value $22M
Cash And Short Term Investments $22M
Inventory -
Current Net Receivables -
Total Non Current Assets $6.5M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $183M
Other Current Assets $1.6M
Other Non Current Assets -
Total Liabilities $15M
Total Current Liabilities $10M
Current Accounts Payable $1.8M
Deferred Revenue -
Current Debt -
Short Term Debt $1.5M
Total Non Current Liabilities $4.8M
Capital Lease Obligations $6.3M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $6.3M
Other Current Liabilities $6.7M
Other Non Current Liabilities -
Total Shareholder Equity $198M
Treasury Stock -
Retained Earnings -$117M
Common Stock $26K
Common Stock Shares Outstanding $19M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$33M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $258K
Capital Expenditures $514K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$70M
Cashflow From Financing $109M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $0
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$42M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$258K
Total Revenue $0
Cost Of Revenue $258K
Costof Goods And Services Sold $258K
Operating Income -$51M
Selling General And Administrative $12M
Research And Development $38M
Operating Expenses $51M
Investment Income Net -
Net Interest Income $8.9M
Interest Income $8.9M
Interest Expense $0
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $258K
Income Before Tax -$42M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$42M
Comprehensive Income Net Of Tax -
Ebit -$42M
Ebitda -$42M
Net Income -$42M

CTNM News

CTNM Profile

Contineum Therapeutics, Inc. Class A Common Stock Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Contineum Therapeutics, Inc. is a clinical-stage biopharmaceutical company located in San Diego, California, focused on developing innovative oral small molecule therapies to address significant unmet medical needs in neuroscience, inflammation, and immunology. The company boasts a robust pipeline driven by advanced research capabilities and a commitment to scientific excellence, positioning itself to deliver effective treatments that enhance patient outcomes. With a strategic focus on addressing critical healthcare challenges, Contineum is poised for substantial growth within the biopharmaceutical industry, making it an attractive prospect for institutional investors.

PTLE
+51.53%
$0.28
VHAI
+21.21%
$0.00
MSPR
+27.56%
$0.66
SCNX
+15.35%
$0.81
EZGO
+29.10%
$0.17
NVDA
-3.95%
$198.69
PFE
-1.37%
$24.32
ORIS
-2.49%
$0.15
BYND
-4.31%
$1.33
HTZ
+36.23%
$6.73
PLTR
-7.93%
$190.74
ASST
-1.57%
$1.25
INTC
-6.25%
$37.03
GRAB
-5.18%
$5.75
ONDS
-3.17%
$5.95
CHR
+9.45%
$0.13
DNN
-6.33%
$2.73
PLUG
-8.36%
$2.52
SOFI
+3.20%
$30.63
WTO
-6.22%
$0.04
CAPT
+31.77%
$0.66
YDKG
-3.39%
$0.05
KVUE
-0.99%
$15.98
NFE
+14.40%
$1.35
F
-0.91%
$13.01
TSLA
-5.09%
$444.48
BITF
-6.56%
$3.84
EPWK
+3.60%
$0.07
T
-0.36%
$24.44
ETHD
+22.28%
$5.31
ACHR
-8.25%
$9.56
AXDX
-61.36%
$0.03
CIFR
-1.09%
$22.51
HIMS
-3.49%
$42.84
GPUS
-7.23%
$0.34
BTBT
-7.01%
$3.18
NCLH
-15.23%
$18.80
AAL
-5.17%
$12.65
BURU
-11.84%
$0.27
RGTI
-10.07%
$35.18
NIO
+2.34%
$7.42
RIVN
-5.23%
$12.50
MARA
-6.68%
$16.62
ADAP
-15.14%
$0.05
AMD
-3.69%
$250.05
BTG
-6.23%
$3.98
AMZN
-1.84%
$249.32
TLRY
-5.34%
$1.24
UBER
-4.99%
$94.74
SOUN
-11.57%
$15.13
PLTZ
+16.06%
$6.07
CAN
-14.46%
$1.11
IREN
-1.65%
$66.63
SNAP
-4.47%
$7.47
VSEE
+3.03%
$1.02
NOK
-4.75%
$6.81
RMBL
+60.50%
$3.21
JOBY
-9.58%
$14.75
AAPL
+0.37%
$270.05
BMNR
-6.91%
$39.89
ADD
-25.47%
$0.05
WULF
-5.40%
$15.22
VALE
+0.90%
$12.20
BAC
-0.07%
$53.52
NGD
-8.11%
$6.68
RIG
-1.64%
$3.89
RXRX
-7.62%
$5.02
CCL
-9.16%
$26.08
NVTS
-8.98%
$12.25
PLTD
+7.99%
$6.35
SRM
+53.27%
$10.30
LUMN
-10.94%
$10.53
WBD
+1.19%
$22.55
DVLT
-3.80%
$1.77
AMCR
+0.12%
$7.87
CDE
-8.85%
$13.80
ABEV
+1.73%
$2.35
GOOGL
+0.89%
$283.72
QBTS
-9.39%
$29.98
RANI
-2.27%
$2.15
IONZ
+17.01%
$4.47
CLF
-10.15%
$10.66
KDLY
-4.41%
$0.88
NAKA
-4.41%
$0.88
WLGS
-5.57%
$0.04
UUUU
-4.43%
$17.01
NVO
-1.76%
$48.24
RR
-8.78%
$4.05
CLSK
-6.88%
$16.22
CGC
-5.83%
$1.12
HPE
-3.93%
$23.53
NEHC
+11.56%
$6.32
AGNC
+1.24%
$10.17
META
-1.62%
$627.32
APLD
-4.56%
$31.37
ETWO
0.00%
$3.30
BBD
-1.01%
$3.41
HOOD
-6.98%
$136.80
CMG
+0.69%
$31.73
VZ
-0.31%
$39.34
PTLE
+51.53%
$0.28
VHAI
+21.21%
$0.00
MSPR
+27.56%
$0.66
SCNX
+15.35%
$0.81
EZGO
+29.10%
$0.17
NVDA
-3.95%
$198.69
PFE
-1.37%
$24.32
ORIS
-2.49%
$0.15
BYND
-4.31%
$1.33
HTZ
+36.23%
$6.73
PLTR
-7.93%
$190.74
ASST
-1.57%
$1.25
INTC
-6.25%
$37.03
GRAB
-5.18%
$5.75
ONDS
-3.17%
$5.95
CHR
+9.45%
$0.13
DNN
-6.33%
$2.73
PLUG
-8.36%
$2.52
SOFI
+3.20%
$30.63
WTO
-6.22%
$0.04
CAPT
+31.77%
$0.66
YDKG
-3.39%
$0.05
KVUE
-0.99%
$15.98
NFE
+14.40%
$1.35
F
-0.91%
$13.01
TSLA
-5.09%
$444.48
BITF
-6.56%
$3.84
EPWK
+3.60%
$0.07
T
-0.36%
$24.44
ETHD
+22.28%
$5.31
ACHR
-8.25%
$9.56
AXDX
-61.36%
$0.03
CIFR
-1.09%
$22.51
HIMS
-3.49%
$42.84
GPUS
-7.23%
$0.34
BTBT
-7.01%
$3.18
NCLH
-15.23%
$18.80
AAL
-5.17%
$12.65
BURU
-11.84%
$0.27
RGTI
-10.07%
$35.18
NIO
+2.34%
$7.42
RIVN
-5.23%
$12.50
MARA
-6.68%
$16.62
ADAP
-15.14%
$0.05
AMD
-3.69%
$250.05
BTG
-6.23%
$3.98
AMZN
-1.84%
$249.32
TLRY
-5.34%
$1.24
UBER
-4.99%
$94.74
SOUN
-11.57%
$15.13
PLTZ
+16.06%
$6.07
CAN
-14.46%
$1.11
IREN
-1.65%
$66.63
SNAP
-4.47%
$7.47
VSEE
+3.03%
$1.02
NOK
-4.75%
$6.81
RMBL
+60.50%
$3.21
JOBY
-9.58%
$14.75
AAPL
+0.37%
$270.05
BMNR
-6.91%
$39.89
ADD
-25.47%
$0.05
WULF
-5.40%
$15.22
VALE
+0.90%
$12.20
BAC
-0.07%
$53.52
NGD
-8.11%
$6.68
RIG
-1.64%
$3.89
RXRX
-7.62%
$5.02
CCL
-9.16%
$26.08
NVTS
-8.98%
$12.25
PLTD
+7.99%
$6.35
SRM
+53.27%
$10.30
LUMN
-10.94%
$10.53
WBD
+1.19%
$22.55
DVLT
-3.80%
$1.77
AMCR
+0.12%
$7.87
CDE
-8.85%
$13.80
ABEV
+1.73%
$2.35
GOOGL
+0.89%
$283.72
QBTS
-9.39%
$29.98
RANI
-2.27%
$2.15
IONZ
+17.01%
$4.47
CLF
-10.15%
$10.66
KDLY
-4.41%
$0.88
NAKA
-4.41%
$0.88
WLGS
-5.57%
$0.04
UUUU
-4.43%
$17.01
NVO
-1.76%
$48.24
RR
-8.78%
$4.05
CLSK
-6.88%
$16.22
CGC
-5.83%
$1.12
HPE
-3.93%
$23.53
NEHC
+11.56%
$6.32
AGNC
+1.24%
$10.17
META
-1.62%
$627.32
APLD
-4.56%
$31.37
ETWO
0.00%
$3.30
BBD
-1.01%
$3.41
HOOD
-6.98%
$136.80
CMG
+0.69%
$31.73
VZ
-0.31%
$39.34
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.